Table 1.
Clinical and demographic characteristics of the study sample (n = 55).
| Overall sample n (%) |
Olanzapine (n = 18) n (%) |
Risperidone (n = 23) n (%) |
Clozapine (n = 14) n (%) |
|
|---|---|---|---|---|
| Age, mean (SD) | 39.3 (8.2) | 37.7 (6.8) | 43.8 (7.7) | 33.9 (6.6) |
| Sex | ||||
| Female | 27 (49.1) | 7 (38.9) | 12 (52.2) | 8 (57.1) |
| Male | 28 (50.9) | 11 (61.1) | 11 (47.8) | 6 (42.9) |
| Ethnicity | ||||
| Chinese | 39 (70.9) | 13 (72.2) | 13 (56.5) | 13 (92.9) |
| Malay | 11 (20.) | 3 (16.7) | 8 (34.8) | 0 (0) |
| Indian | 4 (7.3) | 1 (5.6) | 2 (8.7) | 1 (7.1) |
| Others | 1 (1.8) | 1 (5.6) | 0 (0) | 0 (0) |
| Diagnosis | ||||
| Schizophrenia | 46 (83.6) | 13 (72.2) | 19 (82.6) | 14 (100) |
| Schizoaffective disorder | 9 (16.4) | 5 (27.8) | 4 (17.4) | 0 (0) |
| Medication groups | ||||
| Olanzapine | 18 (32.7) | – | – | – |
| Risperidone | 23 (41.8) | – | – | – |
| Clozapine | 14 (25.5) | – | – | – |
| Dosage (mg/day), mean (SD) | 11.9 (5.7) (range 5–20) | 3.2 (1.6) (range: 0.5–6) |
292.9 (115.8) (range: 125–500) |
|